Drug Trial Radar · NCT01740947
Does Administration of Antibiotics in Patients Undergoing Surgery for Colorectal Cancer Result in Less Complications and Better Prognosis?
Last checked: Nov 19, 2026Latest source record: Nov 9, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
485
Actual
Start
Jan 2013
Primary completion
Mar 2017
Study completion Mar 2017
Sponsor
- Lead sponsor
- H. Jaap Bonjer, PhDAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Dutch Digestive Diseases Foundation
- First posted
- Dec 4, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Supportive care
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objectives of this randomized clinical trial are to evaluate if perioperative SDD can reduce clinical anastomotic leakage rate and its septic consequences as well as other infectious complications. By reduction of septic complications long-term oncological outcome might simultaneously improve.
Conditions
- Colorectal Cancer
Interventions
Selective decontamination of the digestive tract (SDD) (colistin sulfate, tobramycin, amphotericin B)Drug
SDD suspension contains per dose of 10 ml 100 mg colistin sulfate, 80 mg tobramycin and 500 mg amphotericin B
Primary outcomes
What the sponsor says the trial is designed to measure.
- anastomotic leakage and/or abscessTime frame: 30 days postoperatively
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Slotervaart Ziekenhuis
Amsterdam, Netherlands
VU University Medical Center
Amsterdam, Netherlands
Kennemer Gasthuis
Haarlem, Netherlands
Spaarne Ziekenhuis
Hoofddorp, Netherlands
WestFries Gasthuis
Hoorn, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.